N/A
Completed N=8
The Feasibility of Engage Therapy With Video Support for Homebound Older Adults
Source: ClinicalTrials.gov NCT05346055 ↗Enrolled (actual)
8
Serious AEs
0.0%
Results posted
Jun 2023
Primary outcomePrimary: Acceptability: Client Satisfaction Questionnaire (CSQ) — 10.5 score on a scale
Summary
The primary aim in this pilot project is to test the feasibility, acceptability and impact (decreased depressive symptoms) of a brief behavioral treatment for depression (Engage) combined with video social support (PRISM 2.0) among socially isolated/lonely case management clients who endorse depressive symptoms. Eligible participants will be offered the combination of Engage and Prism 2.0, called Engage-Prism. The investigators hypothesize that the intervention (Engage Therapy With Video Support) will be accepted by participants, improve depressive symptom, and be feasible to complete.
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acceptability: Client Satisfaction Questionnaire (CSQ) |
9 | — |
| PRIMARY Feasibility: Client Enrollment |
8 | — |
| SECONDARY Hamilton Depression Rating Scale |
0.5 | — |
Eligibility Criteria
Inclusion Criteria
- Age at least 60 years
- English speaking
- Currently enrolled in case management at in 2 included agencies
- Major depression on the SCID
- 24-item Hamilton Depression Rating Scale (HAM-D) ≥ 19
Exclusion Criteria
- Psychotic depression by SCID-V, i.e. presence of delusions
- High suicide risk, i.e. intent or plan to attempt suicide in the near future
- Presence of any Axis I psychiatric disorder
- Presence of substance abuse other than unipolar major depression
- History of psychiatric disorders, hypomania, are excluded
- Acute or severe medical illness, i.e. delirium, metastatic cancer, decompensated cardiac, liver, or kidney failure, major surgery, stroke, or myocardial infarction during the three months prior to entry; or drugs often causing depression, e.g. steroids, reserpine, alpha- methyl-dopa, tamoxiphen, vincristine
- Current involvement in psychotherapy
- Cognitive impairment (i.e. telephone administered MoCA < 11)
- Currently dwelling in non-community dwelling (e.g. prison, nursing home)
- Hearing that would not allow participants to complete sessions with the RA/therapist
- Vision impairment that would not allow the participant to use the study provided tablet
- Inability to speak English
- Aphasia interfering with communication
- Literacy -assessed by reading a paragraph designed for those at 6th grade reading level
Data sourced from ClinicalTrials.gov (NCT05346055). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.